The Federal Trade Commission’s lawsuit against three large pharmacy-benefit managers over insulin prices is on hold after ...

The FTC lawsuit accuses the PBMs of unfairly limiting access to insulin drugs with lower list prices and steering diabetes ...

The Federal Trade Commission is pressing pause on its legal fight with major pharmacy benefit managers. | The agency ...

A controversial lawsuit brought by the FTC against the largest PBMs over insulin pricing was delayed in part by Trump firings. The former chair is not pleased.

President Donald Trump last month fired FTC Commissioners Rebecca Kelly Slaughter and Alvaro Bedoya, the only two members ...

The Federal Trade Commission has paused an enforcement action alleging pharmacy benefit managers used illegal rebate programs ...

Indianapolis-based drugmaker Eli Lilly and Company has announced price reductions of 70% for its most commonly prescribed insulins, as well as expansion of its Insulin Value Program, capping ...

Ben Hargreaves looks at why insulin’s price is so controversial and whether this could be set to change. It has now been 100 years since the first patient with diabetes received an injection of ...

The plant will make three types of insulin, which Civica has pledged to sell for $30 a vial and $55 for a box of five pens. In 2023, Civica struck a deal to produce insulin for the state of California ...

Oklahoma House lawmakers want to lower Insulin's cost for uninsured Oklahomans with diabetes. One bill that passed the ...

A new piece of legislation designed to make insulin products more affordable has successfully passed the Oklahoma House and ...

Two years ago, California made a bold announcement that it would manufacture a state-branded, low-cost insulin. Drug manufacturers, insurers, economists and diabetics took notice. It had the ...